It is Time to Revise the STRIDE Guidelines Determining Therapeutic Goals for Treat-to-Target in Inflammatory Bowel Disease

被引：18
|
作者：
Pouillon, Lieven [1 ,2 ]
Peyrin-Biroulet, Laurent [1 ]
机构：
[1] Univ Lorraine, Nancy 1, Nancy Univ Hosp, Dept Gastroenterol, Allee Morvan 54, F-54511 Vandoeuvre Les Nancy, France
[2] Imeldaziekenhuis Bonheiden, Imelda GI Clin Res Ctr, Imeldalaan 9, B-2820 Bonheiden, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷 / 04期
关键词：
D O I：
10.1093/ecco-jcc/jjx174
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：509 / 509
页数：1
相关论文
共 50 条
  • [41] Disparate care: rates of treat to target among patients with inflammatory bowel disease
    Haydek, J.
    Oonk, A.
    Cheng, D.
    Ahmed, W.
    Click, B.
    Fennimore, B.
    Gerich, M.
    Hou, J.
    Scott, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 821 - 822
  • [42] Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission
    Selinger, Christian
    Carbonell, Jenelyn
    Kane, John
    Omer, Mandour
    Ford, Alexander Charles
    [J]. FRONTLINE GASTROENTEROLOGY, 2021, 12 (01) : 30 - 38
  • [43] Factors Determining Screening for Osteoporosis in Inflammatory Bowel Disease - Are We Following Guidelines?
    Deconda, Deepthi
    Northrup, Veronika
    Cho, Judy
    Proctor, Deborah
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S436 - S436
  • [44] Keeping the Bowel Regular: The Emerging Role of Treg as a Therapeutic Target in Inflammatory Bowel Disease
    Gibson, David J.
    Ryan, Elizabeth J.
    Doherty, Glen A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (12) : 2716 - 2724
  • [45] Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease
    Sukocheva, Olga A.
    Lukina, Elena
    McGowan, Eileen
    Bishayee, Anupam
    [J]. INFLAMMATORY DISORDERS - PT B, 2020, 120 : 123 - 158
  • [46] NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease
    Zhang, Jiayu
    Zeng, Shuyan
    Wang, Peng
    Chen, Youxiang
    Zeng, Chunyan
    [J]. CURRENT DRUG TARGETS, 2023, 24 (14) : 1106 - 1116
  • [47] Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
    Rutgeerts, Paul
    Vermeire, Severine
    Van Assche, Gert
    [J]. GUT, 2007, 56 (04) : 453 - 455
  • [48] DYSREGULATED POLYAMINES IN THE INFLAMMATORY BOWEL DISEASE GUT - A NOVEL THERAPEUTIC TARGET
    Bailey, J.
    [J]. GUT, 2017, 66 : A247 - A247
  • [49] Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
    Ocansey, Dickson Kofi Wiredu
    Yuan, Jintao
    Wei, Zhiping
    Mao, Fei
    Zhang, Zhaoyang
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2023, 51 (06)
  • [50] Gut microflora: a new target for therapeutic approaches in Inflammatory bowel disease
    Mitsuyama, Keiichi
    Sata, Michio
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (03) : 301 - 312
12345